HIV Vaccine Trials Data Center
SDMC: HIV Vaccine Trials Network
This project manages and analyzes data from HIV vaccine and antibody trials to help speed development of safer, more effective vaccines for people at risk of HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11240321 on NIH RePORTER |
What this research studies
This center collects, secures, and organizes data from HVTN vaccine and monoclonal antibody trials around the world. Statisticians and data experts run analyses, build models, and set up fast-track screening to find vaccine and antibody candidates that trigger strong immune responses, including broadly neutralizing antibodies. They also support laboratories by standardizing and analyzing immunology and virology test results and modeling antibody levels and functions. By using modern, standards-based data systems and safety monitoring, they aim to make trial results reliable and shareable with other researchers.
Who could benefit from this research
Good fit: Ideal candidates are people who meet HVTN clinic enrollment rules, typically healthy adults or individuals at risk of HIV who can join vaccine or monoclonal antibody trials at an enrolling site.
Not a fit: People who are not eligible for HVTN trials (for example due to age, medical exclusions, or not living near an enrolling clinic) may not directly benefit from participating.
Why it matters
Potential benefit: If successful, this work could speed identification of vaccine and antibody approaches that protect people from HIV and improve trial safety.
How similar studies have performed: Statistical and data centers like this have supported many vaccine and antibody trials and helped identify promising candidates, though an effective, widely protective HIV vaccine has not yet been achieved.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Gilbert, Peter B. — Fred Hutchinson Cancer Center
- Study coordinator: Gilbert, Peter B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.